445 related articles for article (PubMed ID: 18625458)
1. Ketone bodies as a therapeutic for Alzheimer's disease.
Henderson ST
Neurotherapeutics; 2008 Jul; 5(3):470-80. PubMed ID: 18625458
[TBL] [Abstract][Full Text] [Related]
2. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases.
Jensen NJ; Wodschow HZ; Nilsson M; Rungby J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233502
[TBL] [Abstract][Full Text] [Related]
3. Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.
Hertz L; Chen Y; Waagepetersen HS
J Neurochem; 2015 Jul; 134(1):7-20. PubMed ID: 25832906
[TBL] [Abstract][Full Text] [Related]
4. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease.
Cunnane SC; Courchesne-Loyer A; St-Pierre V; Vandenberghe C; Pierotti T; Fortier M; Croteau E; Castellano CA
Ann N Y Acad Sci; 2016 Mar; 1367(1):12-20. PubMed ID: 26766547
[TBL] [Abstract][Full Text] [Related]
5. Emerging Therapeutic Promise of Ketogenic Diet to Attenuate Neuropathological Alterations in Alzheimer's Disease.
Uddin MS; Kabir MT; Tewari D; Al Mamun A; Barreto GE; Bungau SG; Bin-Jumah MN; Abdel-Daim MM; Ashraf GM
Mol Neurobiol; 2020 Dec; 57(12):4961-4977. PubMed ID: 32820459
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
7. Intermittent fasting and Alzheimer's disease-Targeting ketone bodies as a potential strategy for brain energy rescue.
Ye YC; Chai SF; Li XR; Wu MN; Cai HY; Wang ZJ
Metab Brain Dis; 2024 Jan; 39(1):129-146. PubMed ID: 37823968
[TBL] [Abstract][Full Text] [Related]
8. Ketogenic Diet: A Promising Neuroprotective Composition for Managing Alzheimer's Diseases and its Pathological Mechanisms.
Sridharan B; Lee MJ
Curr Mol Med; 2022; 22(7):640-656. PubMed ID: 34607541
[TBL] [Abstract][Full Text] [Related]
9. Brain glucose and ketone utilization in brain aging and neurodegenerative diseases.
Kapogiannis D; Avgerinos KI
Int Rev Neurobiol; 2020; 154():79-110. PubMed ID: 32739015
[TBL] [Abstract][Full Text] [Related]
10. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
11. Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications.
Xu Y; Zheng F; Zhong Q; Zhu Y
J Alzheimers Dis; 2023; 92(4):1173-1198. PubMed ID: 37038820
[TBL] [Abstract][Full Text] [Related]
12. Hypometabolism as a therapeutic target in Alzheimer's disease.
Costantini LC; Barr LJ; Vogel JL; Henderson ST
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S16. PubMed ID: 19090989
[TBL] [Abstract][Full Text] [Related]
13. A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease.
Newport MT; VanItallie TB; Kashiwaya Y; King MT; Veech RL
Alzheimers Dement; 2015 Jan; 11(1):99-103. PubMed ID: 25301680
[TBL] [Abstract][Full Text] [Related]
14. Regulation of glucose and ketone-body metabolism in brain of anaesthetized rats.
Ruderman NB; Ross PS; Berger M; Goodman MN
Biochem J; 1974 Jan; 138(1):1-10. PubMed ID: 4275704
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
VanItallie TB
Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
[TBL] [Abstract][Full Text] [Related]
16. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.
Reger MA; Henderson ST; Hale C; Cholerton B; Baker LD; Watson GS; Hyde K; Chapman D; Craft S
Neurobiol Aging; 2004 Mar; 25(3):311-4. PubMed ID: 15123336
[TBL] [Abstract][Full Text] [Related]
17. Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester.
Hashim SA; VanItallie TB
J Lipid Res; 2014 Sep; 55(9):1818-26. PubMed ID: 24598140
[TBL] [Abstract][Full Text] [Related]
18. [Beneficial effects of ketogenic diet for Alzheimer's disease management].
Charlot A; Lernould A; Plus I; Zoll J
Biol Aujourdhui; 2023; 217(3-4):253-263. PubMed ID: 38018953
[TBL] [Abstract][Full Text] [Related]
19. Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention.
Ding F; Yao J; Rettberg JR; Chen S; Brinton RD
PLoS One; 2013; 8(11):e79977. PubMed ID: 24244584
[TBL] [Abstract][Full Text] [Related]
20. Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders.
Spigoni V; Cinquegrani G; Iannozzi NT; Frigeri G; Maggiolo G; Maggi M; Parello V; Dei Cas A
Front Endocrinol (Lausanne); 2022; 13():972890. PubMed ID: 36339405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
